[1]朱宇飞,谢华,唐维兵.胆道闭锁中胆管上皮细胞与免疫细胞相互作用的研究进展[J].临床小儿外科杂志,2026,(06):596-600.[doi:10.3760/cma.j.cn101785-202412050]
 Zhu Yufei,Xie Hua,Tang Weibing.Research advances of crosstalking between biliary epithelial cell and immune cells in biliary atresia[J].Journal of Clinical Pediatric Surgery,2026,(06):596-600.[doi:10.3760/cma.j.cn101785-202412050]
点击复制

胆道闭锁中胆管上皮细胞与免疫细胞相互作用的研究进展

参考文献/References:

[1] Tam PKH,Wells RG,Tang CSM,et al.Biliary atresia[J].Nat Rev Dis Primers,2024,10(1):47.DOI:10.1038/s41572-024-00533-x.
[2] Quelhas P,Cerski C,Dos Santos JL.Update on etiology and pathogenesis of biliary atresia[J].Curr Pediatr Rev,2022,19(1):48-67.DOI:10.2174/1573396318666220510130259.
[3] Cullis PS,Fouad D,Goldstein AM,et al.Major surgical conditions of childhood and their lifelong implications:comprehensive review[J].BJS Open,2024,8(3):zrae028.DOI:10.1093/bjsopen/zrae028.
[4] Wong CWY,Chung PHY,Tam PKH,et al.Long-term results and quality of life assessment in biliary atresia patients:a 35-year experience in a tertiary hospital[J].J Pediatr Gastroenterol Nutr,2018,66(4):570-574.DOI:10.1097/MPG.0000000000001854.
[5] Grama A,Mititelu A,S?rbe C,et al.Immune-mediated cholangiopathies in children:the need to better understand the pathophysiology for finding the future possible treatment targets[J].Front Immunol,2023,14:1206025.DOI:10.3389/fimmu.2023.1206025.
[6] Jalan-Sakrikar N,Guicciardi ME,O’Hara SP,et al.Central role for cholangiocyte pathobiology in cholestatic liver diseases[J].Hepatology,2025,18(2):834-854.DOI:10.1097/hep.0000000000001093.
[7] Chusilp S,Balsamo F,Li B,et al.Development of liver inflammatory injury in biliary atresia:from basic to clinical research[J].Pediatr Surg Int,2023,39(1):207.DOI:10.1007/s00383-023-05489-9.
[8] Vij M,Rela M.Biliary atresia:pathology,etiology and pathogenesis[J].Future Sci OA,2020,6(5):Article:FSO466.DOI:10.2144/fsoa-2019-0153.
[9] Zhang HY,Leung PSC,Gershwin ME,et al.How the biliary tree maintains immune tolerance?[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(4,Part B):1367-1373.DOI:10.1016/j.bbadis.2017.08.019.
[10] Otani T,Furuse M.Tight junction structure and function revisited[J].Trends Cell Biol,2020,30(10):805-817.DOI:10.1016/j.tcb.2020.08.004.
[11] Babu RO,Lui VCH,Chen Y,et al.Beta-amyloid deposition around hepatic bile ducts is a novel pathobiological and diagnostic feature of biliary atresia[J].J Hepatol,2020,73(6):1391-1403.DOI:10.1016/j.jhep.2020.06.012.
[12] Amarachintha SP,Mourya R,Ayabe H,et al.Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia[J].Hepatology,2022,75(1):89-103.DOI:10.1002/hep.32107.
[13] Yue HB,Sivasankaran MS,Ottakandathil BR,et al.Environmental toxin biliatresone-induced biliary atresia-like abnormal cilia and bile duct cell development of human liver organoids[J].Toxins (Basel),2024,16(3):144.DOI:10.3390/toxins16030144.
[14] Zhou YJ,Ji HJ,Xu Q,et al.Congenital biliary atresia is correlated with disrupted cell junctions and polarity caused by Cdc42 insufficiency in the liver[J].Theranostics,2021,11(15):7262-7275.DOI:10.7150/thno.49116.
[15] Karjoo S,Hand NJ,Loarca L,et al.Extrahepatic cholangiocyte cilia are abnormal in biliary atresia[J].J Pediatr Gastroenterol Nutr,2013,57(1):96-101.DOI:10.1097/MPG.0b013e318296e525.
[16] Lam WY,Tang CSM,So MT,et al.Identification of a wide spectrum of ciliary gene mutations in nonsyndromic biliary atresia patients implicates ciliary dysfunction as a novel disease mechanism[J].EBioMedicine,2021,71:103530.DOI:10.1016/j.ebiom.2021.103530.
[17] Berauer JP,Mezina AI,Okou DT,et al.Identification of polycystic kidney disease 1 like 1 gene variants in children with biliary atresia splenic malformation syndrome[J].Hepatology,2019,70(3):899-910.DOI:10.1002/hep.30515.
[18] Lim YZ,Zhu M,Wang Y,et al.Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells[J].J Hepatol,2024,81(1):62-75.DOI:10.1016/j.jhep.2024.02.031.
[19] Glessner JT,Ningappa MB,Ngo KA,et al.Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes[J].J Hepatol,2023,79(6):1385-1395.DOI:10.1016/j.jhep.2023.07.039.
[20] Fitzgerald KA,Kagan JC.Toll-like receptors and the control of immunity[J].Cell,2020,180(6):1044-1066.DOI:10.1016/j.cell.2020.02.041.
[21] Li Y,Li TY,Qi Q,et al.Human poliovirus receptor contributes to biliary atresia pathogenesis by exacerbating natural-killer-cell-mediated bile duct injury[J].Liver Int,2022,42(12):2724-2742.DOI:10.1111/liv.15457.
[22] Okamura A,Harada K,Nio M,et al.Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia[J].J Clin Pathol,2013,66(2):99-108.DOI:10.1136/jclinpath-2012-201097.
[23] Shimada T,Imaizumi T,Shirai K,et al.CCL5 is induced by TLR 3 signaling in HuCCT1 human biliary epithelial cells:possible involvement in the pathogenesis of biliary atresia[J].Biomed Res,2017,38(5):269-276.DOI:10.2220/biomedres.38.269.
[24] Okamura A,Harada K,Nio M,et al.Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia[J].Clin Exp Immunol,2013,173(2):268-275.DOI:10.1111/cei.12103.
[25] Wu Y,Liu TZ,Yuan YH,et al.Gene expression profile of TLR7 signaling pathway in the liver of rhesus rotavirus-induced murine biliary atresia[J].Biochem Biophys Res Commun,2018,503(1):291-296.DOI:10.1016/j.bbrc.2018.06.018.
[26] Huang YH,Shih HH,Tiao MM,et al.Toll-like receptor 7 agonist induces hypoplasia of the biliary system in a neonatal mouse model[J].J Microbiol Immunol Infect,2018,51(2):166-173.DOI:10.1016/j.jmii.2016.07.002.
[27] Hu ZH,Chai JJ.Assembly and architecture of NLR resistosomes and inflammasomes[J].Annu Rev Biophys,2023,52:207-228.DOI:10.1146/annurev-biophys-092922-073050.
[28] Yang L,Mizuochi T,Shivakumar P,et al.Regulation of epithelial injury and bile duct obstruction by NLRP3,IL-1R1 in experimental biliary atresia[J].J Hepatol,2018,69(5):1136-1144.DOI:10.1016/j.jhep.2018.05.038.
[29] Berntsen NL,Fosby B,Tan C,et al.Natural killer T cells mediate inflammation in the bile ducts[J].Mucosal Immunol,2018,11(6):1582-1590.DOI:10.1038/s41385-018-0066-8.
[30] Cui MM,Gong YM,Pan WH,et al.Contribution of ADD3 and the HLA genes to biliary atresia risk in Chinese[J].Int J Mol Sci,2023,24(19):14719.DOI:10.3390/ijms241914719.
[31] Barnes BH,Tucker RM,Wehrmann F,et al.Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia[J].Liver Int,2009,29(8):1253-1261.DOI:10.1111/j.1478-3231.2008.01921.x.
[32] Zheng SY,Zhang HY,Zhang XJ,et al.CD8+ T lymphocyte response against extrahepatic biliary epithelium is activated by epitopes within NSP4 in experimental biliary atresia[J].Am J Physiol Gastrointest Liver Physiol,2014,307(2):G233-G240.DOI:10.1152/ajpgi.00099.2014.
[33] Li Y,Li TY,Qiao Q,et al.Polymeric immunoglobulin receptor promotes Th2 immune response in the liver by increasing cholangiocytes derived IL-33:a diagnostic and therapeutic biomarker of biliary atresia[J].EBioMedicine,2024,108:105344.DOI:10.1016/j.ebiom.2024.105344.
[34] Shivakumar P,Sabla G,Mohanty S,et al.Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia[J].Gastroenterology,2007,133(1):268-277.DOI:10.1053/j.gastro.2007.04.031.
[35] Lages CS,Simmons J,Maddox A,et al.The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia[J].Hepatology,2017,65(1):174-188.DOI:10.1002/hep.28851.
[36] Mohanty SK,Donnelly B,Temple H,et al.T-bet deficiency attenuates bile duct injury in experimental biliary atresia[J].Cells,2021,10(12):3461.DOI:10.3390/cells10123461.
[37] Guo XJ,Xu YP,Luo W,et al.Programmed cell death protein-1(PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice[J].BMC Pediatr,2021,21(1):317.DOI:10.1186/s12887-021-02794-x.
[38] Dong R,Zhao R,Zheng S.Changes in epigenetic regulation of CD4+ T lymphocytesin biliary atresia[J].Pediatr Res,2011,70(6):555-559.DOI:10.1203/PDR.0b013e318232a949.
[39] M?hn N,Bruni E,Schr?der A,et al.Synthetic retinoid AM80 inhibits IL-17 production of gamma delta T cells and ameliorates biliary atresia in mice[J].Liver Int,2020,40(12):3031-3041.DOI:10.1111/liv.14639.
[40] Oita S,Saito T,Hashimoto R,et al.Frequency of infiltrating regulatory T-cells in the portal tract of biliary atresia[J].Pediatr Surg Int,2023,39(1):259.DOI:10.1007/s00383-023-05547-2.
[41] Li K,Zhang X,Yang L,et al.Foxp3 promoter methylation impairs suppressive function of regulatory T cells in biliary atresia[J].Am J Physiol Gastrointest Liver Physiol,2016,311(6):G989-G997.DOI:10.1152/ajpgi.00032.2016.
[42] Luo YH,Bednarek J,Chaidez A,et al.Regulatory T cell (Treg) cytotoxic T lymphocyte-associated antigen-4 deficits in biliary atresia (BA) and disease rescue with Treg augmentation in murine BA[J].Gastro Hep Adv,2022,1(3):461-470.DOI:10.1016/j.gastha.2021.12.012.
[43] Chen C,Wang HZ,Xu LL,et al.MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia[J].Clin Immunol,2024,268:110355.DOI:10.1016/j.clim.2024.110355.
[44] Lages CS,Simmons J,Chougnet CA,et al.Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia[J].Hepatology,2012,56(1):219-227.DOI:10.1002/hep.25662.
[45] Miethke AG,Saxena V,Shivakumar P,et al.Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia[J].J Hepatol,2010,52(5):718-726.DOI:10.1016/j.jhep.2009.12.027.
[46] Liu YJ,Li K,Yang L,et al.Dendritic cells regulate Treg-Th17 axis in obstructive phase of bile duct injury in murine biliary atresia[J].PLoS One,2015,10(9):e0136214.DOI:10.1371/journal.pone.0136214.
[47] Liu MT,Zhu Y,Meng WD,et al.Potential therapeutic effect of dimethyl fumarate on Treg/Th17 cell imbalance in biliary atresia[J].Clin Immunol,2025,272:110439.DOI:10.1016/j.clim.2025.110439.
[48] Wang J,Xu YH,Chen ZH,et al.Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia[J].Cell,2020,183(7):1867-1883.e26.DOI:10.1016/j.cell.2020.10.048.
[49] Luo YH,Brigham D,Bednarek J,et al.Unique cholangiocyte-targeted IgM autoantibodies correlate with poor outcome in biliary atresia[J].Hepatology,2021,73(5):1855-1867.DOI:10.1002/hep.31504.
[50] Lu BR,Brindley SM,Tucker RM,et al.α-Enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia[J].Gastroenterology,2010,139(5):1753-1761.DOI:10.1053/j.gastro.2010.07.042.
[51] Qiu YR,Yang JX,Wang WM,et al.HMGB1-promoted and TLR2/4-dependent NK cell maturation and activation take part in rotavirus-induced murine biliary atresia[J].PLoS Pathog,2014,10(3):e1004011.DOI:10.1371/journal.ppat.1004011.
[52] Zhang RZ,Lin ZF,Fu M,et al.The role of neonatal Gr-1+myeloid cells in a murine model of rhesus-rotavirus-induced biliary atresia[J].Am J Pathol,2018,188(11):2617-2628.DOI:10.1016/j.ajpath.2018.07.024.
[53] Ye RC,Ma SG,Chen Y,et al.Single cell RNA-sequencing analysis reveals that N-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia[J].JHEP Rep,2023,5(11):100908.DOI:10.1016/j.jhepr.2023.100908.
[54] Xiao MH,Wu SH,Liang PS,et al.Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresia[J].EBioMedicine,2024,103:105138.DOI:10.1016/j.ebiom.2024.105138.

相似文献/References:

[1]刘钢高昕刘树立黄柳明王伟邵培侯文英张军李龙.胆道闭锁葛西手术后肝内胆管扩张的治疗与预后分析[J].临床小儿外科杂志,2010,9(03):0.
 LIU Gang,GAO Xin,LIU Shu-li,et al.The managements and prognosis of intrahepatic biliary dilatation with biliary atresia after Kasai procedure[J].Journal of Clinical Pediatric Surgery,2010,9(06):0.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[3]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[4]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
 [J].Journal of Clinical Pediatric Surgery,2012,11(06):187.
[5]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[6]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[7]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[8]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[9]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[10]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.

备注/Memo

收稿日期:2024-12-17。
基金项目:国家自然科学基金(82370523)
通讯作者:唐维兵,Email:twbcn@163.com

更新日期/Last Update: 1900-01-01